EUVIMEDEUVIMED entdecken
Crossref

Synthesis, In Vitro Anticancer Activity, Molecular Docking, and Dynamic Simulation Study of Thiazole‐Conjugated Pyrazole Derivatives

Deepali M Wanode iD, Pramod B Khedekar, Somdatta Y Chaudhari

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Deepali M Wanode und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India. Hauptthemen laut MEDLINE: Pyrazoles, Antineoplastic Agents, Thiazoles, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we successfully designed and developed novel hybrid compounds integrating thiazole and pyrazole pharmacophores through a molecular hybridization approach. The synthesis was carried out through the Vilsmeier–Haack reaction, and the structural elucidation of these hybrids was achieved using FTIR, 1 H NMR, 13 C NMR, and high‐resolution mass spectrometry (HRMS). The in vitro anticancer potency was evaluated against the MCF‐7 cell line. Notably, compound IVc exhibited the highest anticancer activity among all tested compounds, with an IC 50 value of 126.98 µM, compared to standard 5‐fluorouracil (IC 50 = 69.64 µM). Molecular docking studies with VEGFR‐2 kinase (PDB ID: 4ASD) revealed the strong interactions between compound IVc and key residues, including CYS919A, LEU840A, VAL848A, VAL848A, ALA866A, VAL916A, PHE918A, LEU1035A, and PHE1047A. These findings were further validated by molecular dynamic simulations, which confirmed the structural stability of ligand–receptor complex over the entirety of the 100 ns simulation. Additionally, ADMET predictions indicated favorable pharmacokinetic properties, including excellent intestinal absorption, absence of hepatotoxicity, and strong drug‐like characteristics. Collectively, this work provides valuable insights for designing thiazole–pyrazole derivatives as promising candidates for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesAntineoplastic AgentsThiazolesMolecular Docking SimulationHumansDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureMolecular Dynamics SimulationMCF-7 CellsVascular Endothelial Growth Factor Receptor-2Dose-Response Relationship, DrugProtein Kinase Inhibitors

Stichwörter der Autor:innen

ADMETcancermolecular dockingmolecular dynamics simulationpyrazolethiazole

Substanzen

PyrazolesAntineoplastic AgentsThiazolesVascular Endothelial Growth Factor Receptor-2pyrazoleProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India.
  • Department of Pharmaceutical Chemistry, PES's Modern College of Pharmacy, Pune, Maharashtra, India.

ORCID-Profile: Deepali M Wanode

Zitieren

APA

Wanode, D. M., Khedekar, P. B., & Chaudhari, S. Y. (2025). Synthesis, In Vitro Anticancer Activity, Molecular Docking, and Dynamic Simulation Study of Thiazole‐Conjugated Pyrazole Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501138

Vancouver

Wanode DM, Khedekar PB, Chaudhari SY. Synthesis, In Vitro Anticancer Activity, Molecular Docking, and Dynamic Simulation Study of Thiazole‐Conjugated Pyrazole Derivatives. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501138

BibTeX
@article{Wanode2025,
  author = {Wanode, Deepali M and Khedekar, Pramod B and Chaudhari, Somdatta Y},
  title = {Synthesis, In Vitro Anticancer Activity, Molecular Docking, and Dynamic Simulation Study of Thiazole‐Conjugated Pyrazole Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501138}
}
Kostenlos starten →